Production of recombinant tumor necrosis factor receptor/Fc fusion protein by genetically manipulated chickens

Journal of Bioscience and Bioengineering

Volumn 105, Issue 5, 2008, Pages 454-459

  Kyogoku, Kenji ^a   Yoshida, Kazuhiro ^b   Watanabe, Hiroyuki ^a   Yamashita, Takashi ^a   Kawabe, Yoshinori ^b   Motono, Makoto ^b   Nishijima, Ken Ichi ^b   Kamihira, Masamichi ^b   Iijima, Shinji ^b  

^a KANEKA CORPORATION   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

genetically manipulated chicken; pharmaceutical protein; transgenic avian bioreactor; tumor necrosis factor receptor Fc; yolk transport

Indexed keywords

BIOMOLECULES; BIOTECHNOLOGY; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; FUSION REACTIONS; GLYCOPROTEINS; MACROPHAGES; NUCLEAR PHYSICS; PATIENT TREATMENT; PROTEINS; TECHNOLOGY; TISSUE; TUMORS; VECTORS;

CHICKEN EMBRYOS; CYTOTOXIC ACTIVITIES; EGG YOLKS; EXPRESSION CASSETTE; EXTRACELLULAR DOMAINS; FC REGION; FUSION PROTEINS; INFLAMMATORY DISEASES; RECEPTOR (IR); RECOMBINANT PROTEINS; RETROVIRAL VECTORS; RHEUMATOID ARTHRITIS (RA); TUMOR NECROSIS FACTOR (NCF); VIRAL VECTORS;

BODY FLUIDS;

ETANERCEPT; FC RECEPTOR; IMMUNOGLOBULIN G1; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STRAIN L 929; CHICK EMBRYO; CHICKEN; DRUG ISOLATION; DRUG SYNTHESIS; EGG YOLK; EMBRYO CULTURE; PROTEIN ENGINEERING; PROTEIN SYNTHESIS; TRANSGENE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHICKENS; EGG YOLK; IMMUNOGLOBULIN G; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

AVES; GALLUS GALLUS;

EID: 44949150169     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.105.454     Document Type: Article

References (35)

1. Rudolph N.S. Biopharmaceutical production in transgenic livestock. Trends Biotechnol. 17 (1999) 367-374
2. Kues W.A., and Niemann H. The contribution of farm animals to human health. Trends Biotechnol. 22 (2004) 286-294
3. Houdebine L.M. Transgenic animal bioreactors. Transgenic Res. 9 (2000) 305-320
4. Ivarie R. Avian transgenesis: progress towards the promise. Trends Biotechnol. 21 (2003) 14-19
5. Sang H. Prospects for transgenesis in the chick. Mech. Dev. 121 (2004) 1179-1186
6. Harvey A.J., Speksnijder G., Baugh L.R., Morris J.A., and Ivarie R. Expression of exogenous protein in the egg white of transgenic chickens. Nat. Biotechnol. 20 (2002) 396-399
7. Zhu L., van de Lavoir M.C., Albanese J., Beenhouwer D.O., Cardarelli P.M., Cuison S., Deng D.F., Deshpande S., Diamond J.H., Green L., et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat. Biotechnol. 23 (2005) 1159-1169
8. Kamihira M., Ono K., Esaka K., Nishijima K., Kigaku R., Komatsu H., Yamashita T., Kyogoku K., and Iijima S. High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector. J. Virol. 79 (2005) 10864-10874
9. Kawabe Y., Kamihira M., Ono K., Kyogoku K., Nishijima K., and Iijima S. Production of scFv-Fc fusion protein using genetically manipulated quails. J. Biosci. Bioeng. 102 (2006) 297-303
10. Rapp J.C., Harvey A.J., Speksnijder G.L., Hu W., and Ivarie R. Biologically active human interferon α-2b produced in the egg white of transgenic hens. Transgenic Res. 12 (2003) 569-575
11. Cutting J.A., and Roth T.F. Changes in specific sequestration of protein during transport into the developing oocyte of the chicken. Biochim. Biophys. Acta 298 (1973) 951-955
12. Loeken M.R., and Roth T.F. Analysis of maternal IgG subpopulations which are transported into the chicken oocyte. Immunology 49 (1983) 21-28
13. Schneider W.J., Osanger A., Waclawek M., and Nimpf J. Oocyte growth in the chicken: receptors and more. Biol. Chem. 379 (1998) 965-971
14. Ward E.S. Acquiring maternal immunoglobulin: different receptors, similar functions. Immunity 20 (2004) 507-508
15. Kowalczyk K., Daiss J., Halpern J., and Roth T.F. Quantitation of maternal-fetal IgG transport in the chicken. Immunology 54 (1985) 755-762
16. Morrison S.L., Mohammed M.S., Wims L.A., Trinh R., and Etches R. Sequences in antibody molecules important for receptor-mediated transport into the chicken egg yolk. Mol. Immunol. 38 (2002) 619-625
17. Kawabe Y., Naka T., Ando-Noumi N., Matsumoto H., Ono K., Nishijima K., Kamihira M., and Iijima S. Transport of human immunoglobulin G and Fc-fusion proteins to chicken egg yolk. J. Biosci. Bioeng. 102 (2006) 518-523
18. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
19. Mohler K.M., Torrance D.S., Smith C.A., Goodwin R.G., Stremler K.E., Fung V.P., Madani H., and Widmer M.B. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151 (1993) 1548-1561
20. Loetscher H., Steinmetz M., and Lesslauer W. Tumor necrosis factor: receptors and inhibitors. Cancer Cells 3 (1991) 221-226
21. Peppel K., Crawford D., and Beutler B. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174 (1991) 1483-1489
22. Howard O.M., Clouse K.A., Smith C., Goodwin R.G., and Farrar W.L. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proc. Natl. Acad. Sci. USA 90 (1993) 2335-2339
23. Wooley P.H., Dutcher J., Widmer M.B., and Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J. Immunol. 151 (1993) 6602-6607
24. Larché M.J., Sacre S.M., and Foxwell B.M. Pathogenic role of TNF α in rheumatoid arthritis. Drug Discov. Today: Dis. Mech. 2 (2005) 367-375
25. Goffe B., and Cather J.C. Etanercept: an overview. J. Am. Acad. Dermatol. 49 (2003) S105-S111
26. Hawley R.G., Lieu F.H.L., Fong A.Z.C., and Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1 (1994) 136-138
27. Hotta A., Saito Y., Kyogoku K., Kawabe Y., Nishijima K., Kamihira M., and Iijima S. Characterization of transient expression system for retroviral vector production. J. Biosci. Bioeng. 101 (2006) 361-368
28. Julius M.A., Yan Q., Zheng Z., and Kitajewski J. Q vectors, bicistronic retroviral vectors for gene transfer. Biotechniques 28 (2000) 702-708
29. Zufferey R., Donello J.E., Trono D., and Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73 (1999) 2886-2892
30. Mizuarai S., Ono K., Yamaguchi K., Nishijima K., Kamihira M., and Iijima S. Production of transgenic quails with high frequency of germ-line transmission using VSV-G pseudotyped retroviral vector. Biochem. Biophys. Res. Commun. 286 (2001) 456-463
31. Perry M.M. A complete culture system for the chick embryo. Nature 331 (1988) 70-72
32. Kamihira M., Oguchi S., Tachibana A., Kitagawa Y., and Iijima S. Improved hatching for in vitro quail embryo culture using surrogate eggshell and artificial vessel. Dev. Growth Differ. 40 (1998) 449-455
33. Hamburger V., and Hamilton H.L. A series of normal stages in the development of the chick embryo. J. Morphol. 88 (1951) 49-92
34. Flick D.A., and Gifford G.E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68 (1984) 167-175
35. Hamal K.R., Burgess S.C., Pevzner I.Y., and Erf G.F. Maternal antibody transfer from dams to their egg yolks, egg whites, and chicks in meat lines of chickens. Poult. Sci. 85 (2006) 1364-1372